Now showing items 1-14 of 14
Keywords |
---|
access [1] |
Allogeneic [1] |
biomarker [5] |
cost-effectiveness [2] |
Farmacoeconomy [1] |
Hematopoietic cell transplant [1] |
immunotherapy [5] |
Late effects [1] |
nivolumab [1] |
PD-L1 [2] |
Personalized Medicine [2] |
pooled analysis [1] |
Severe aplastic anemia [1] |
Survivorship [1] |
Now showing items 1-14 of 14